← All organizations
Highest phase reached
Phase 2
First clinical trial
Feb 1, 2014Last known activity
Jan 31, 2023
Timeline
2010s
- Jan 1, 2010
Calithera Biosciences— Founded
Drugs by trial phase (29 distinct, 21 trials)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (8 own, 0 via acquisition)
Indications
Studied for
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Cystic Fibrosis
- Fibrosis
- Gastrointestinal Stromal Tumors
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myelomonocytic, Juvenile
- Lung Neoplasms
- Lymphoma, Non-Hodgkin
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Preleukemia
- Syndrome
- Triple Negative Breast Neoplasms
- Waldenstrom Macroglobulinemia
Recent trials (34)
- NCT05521997CollaboratorPhase 2Jan 31, 2023
- NCT05319028Lead sponsorPhase 2Jun 23, 2022
- NCT05275673Lead sponsorPhase 2Apr 15, 2022
- NCT05275673Study directorPhase 2Apr 15, 2022
- NCT04824937CollaboratorPhase 2Jul 31, 2021
- NCT04607512Lead sponsorPhase 1Oct 5, 2020
- NCT04540965Lead sponsorPhase 1Sep 22, 2020
- NCT04279769Lead sponsorPhase 1Apr 30, 2020
- NCT04279769Study directorPhase 1Apr 30, 2020
- NCT04265534Study directorPhase 2Apr 30, 2020
- NCT04265534Lead sponsorPhase 2Apr 30, 2020
- NCT03965845Study directorPhase 1/Phase 2Jun 30, 2019
- NCT03965845Lead sponsorPhase 1/Phase 2Jun 30, 2019
- NCT03875313Study directorPhase 1/Phase 2Mar 31, 2019
- NCT03875313Lead sponsorPhase 1/Phase 2Mar 31, 2019
Details
- Founded
- San Francisco, CA, US Jan 1, 2010
- Last known activity
- Jan 31, 2023
Notes
--- Pre-folding founded info: 2010-06-01 South San Francisco CA United States https://www.crunchbase.com/organization/calithera-biosciences ---